Li Linzi, Alonso Alvaro, Romaguera Dora, Alonso-Gómez Angel M, Razquin Cristina, Tojal-Sierra Lucas, Fiol Miquel, Martínez-González Miguel Angel, Subramanya Vinita, Salas-Salvadó Jordi, Fito Montserrat, Toledo Estefanía
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
J Clin Med. 2024 Apr 7;13(7):2132. doi: 10.3390/jcm13072132.
: Lifestyles influence atrial fibrillation (AF) risk. Determining the effect of lifestyle interventions on blood concentrations of biomarkers of AF-related pathways could help understand AF pathophysiology and contribute to AF prevention. : We studied 532 participants enrolled in the PREDIMED-Plus trial, a Spanish randomized trial conducted in adults (55-75 years) with metabolic syndrome and body mass index between 27-40 kg/m. Eligible participants were randomized 1:1 to an intensive lifestyle intervention, emphasizing physical activity, weight loss, and adherence to an energy-reduced Mediterranean diet or to a control group. Serum biomarkers [carboxy-terminal propeptide of procollagen type I (PICP), high-sensitivity troponin T (hsTnT), high-sensitivity C reactive protein (hsCRP), 3-nitrotyrosine (3-NT), and N-terminal propeptide of B-type natriuretic peptide (NT-proBNP)] were measured at baseline, 3 and 5 years after randomization. Mixed models were used to evaluate the effect of intervention on changes in biomarkers through year 5. Mediation analysis was performed to examine the proportion mediated by each component of the intervention. : At baseline, participants' mean age was 65, 40% were female, and 50% were assigned to the intervention. After five years, mean changes in log-transformed biomarkers were -0.01 (PICP), 0.20 (hsTnT), -0.17 (hsCRP), 0.12 (3-NT), and 0.27 (NT-proBNP). Compared to the control group, participants in the intervention group experienced greater decreases in hsCRP (-14%, 95% confidence interval (CI) -26%, 0%) or smaller increases in 3-NT (-16%, 95% CI -25%, -5%) and NT-proBNP (-12%, 95% CI -23%, 1%). The intervention had minimal impact on hsTnT (-3%, 95% CI -7%, 2%) or PICP concentrations (-2%, 95% CI -9%, 6%). The effect of the intervention on hsCRP was primarily mediated by weight loss (89% at year 5). : Over five years, a dietary and lifestyle intervention for weight-loss favorably affected concentrations of hsCRP, 3-NT, and NT-proBNP, pointing to specific mechanisms in pathways linking lifestyles and AF.
生活方式会影响房颤(AF)风险。确定生活方式干预对房颤相关通路生物标志物血液浓度的影响,有助于理解房颤的病理生理学,并有助于预防房颤。
我们研究了参与PREDIMED-Plus试验的532名参与者,该试验是一项在西班牙进行的针对患有代谢综合征且体重指数在27至40kg/m²之间的成年人(55至75岁)的随机试验。符合条件的参与者被1:1随机分配至强化生活方式干预组,该组强调体育活动、体重减轻以及坚持低能量地中海饮食,或分配至对照组。在基线、随机分组后3年和5年时测量血清生物标志物[I型前胶原羧基末端前肽(PICP)、高敏肌钙蛋白T(hsTnT)、高敏C反应蛋白(hsCRP)、3-硝基酪氨酸(3-NT)和B型利钠肽N末端前体(NT-proBNP)]。使用混合模型评估干预对至第5年时生物标志物变化的影响。进行中介分析以检验干预各组成部分所介导的比例。
在基线时,参与者的平均年龄为65岁,40%为女性,50%被分配至干预组。5年后,经对数转换的生物标志物的平均变化分别为-0.01(PICP)、0.20(hsTnT)、-0.17(hsCRP)、0.12(3-NT)和0.27(NT-proBNP)。与对照组相比,干预组参与者的hsCRP下降幅度更大(-14%,95%置信区间(CI)-26%,0%),3-NT(-16%,95%CI -25%,-5%)和NT-proBNP(-12%,95%CI -23%,1%)的升高幅度更小。干预对hsTnT(-3%,95%CI -7%,2%)或PICP浓度(-2%,95%CI -9%,6%)的影响最小。干预对hsCRP的影响主要由体重减轻介导(第5年时为89%)。
在5年期间,一项旨在减肥的饮食和生活方式干预对hsCRP、3-NT和NT-proBNP的浓度产生了有利影响,这表明了生活方式与房颤之间通路中的特定机制。